Portal Bioscience
Ben and Joel Credle are co-founders and Ben currently serves as interim chief scientific officer.
ImmuneID
Ben is a co-founder and member of the scientific advisory board.
CDI Laboratories
Ben is entitled to royalties for products and services related to PhIP-Seq and VirScan.
TScan Therapeutics
Ben currently serves on the scientific advisory board.
Alchemab Therapeutics
Ben is a co-founder.